Table 3 Univariate mediation analysis revealed the mediating role of anemia biomarkers in the association between the eGFR and all-cause mortality.
Hb | Hct | RDW | MCHC | |||||
---|---|---|---|---|---|---|---|---|
Mediation (%) | 95% CI | Mediation (%) | 95% CI | Mediation (%) | 95% CI | Mediation (%) | 95% CI | |
Total | 14.84 | 8.62 to 21.07 | 15.14 | 9.22 to 21.07 | 36.48 | 29.96 to 43.01 | 0.21 | − 6.12 to 6.53 |
Age groups (years) | ||||||||
20–45 | 152.48 | NA* | 26.26 | NA | 88.42 | NA | − 56.37 | NA |
46–64 | 8.15 | − 1.30 to 17.60 | 2.62 | − 2.01 to 9.21 | 16.3 | 4.62 to 36.12 | − 1.67 | 6.55 to 1.34 |
65 or older | 22.70 | 18.09 to 27.32 | 22.71 | 18.33 to 27.09 | 25.11 | 20.56 to 29.66 | 0.14 | − 4.47 to 4.75 |
eGFR groups | ||||||||
Early CKD | 12.20 | 10.90 to 13.50 | 11.88 | 10.70 to 13.07 | − 3.32 | − 4.69 to − 1.95 | − 0.23 | − 1.48 to 1.01 |
CKD | 17.55 | 16.52 to 18.58 | 17.60 | 16.36 to 18.84 | 36.19 | 34.76 to 37.61 | 0.15 | − 1.01 to 1.31 |
Hb groups | ||||||||
Anemia | 29.30 | 27.98 to 30.62 | 28.28 | 27.19 to 30.62 | 13.04 | 12.01 to 14.06 | − 1.06 | − 1.96 to − 0.16 |
No anemia | -0.22 | − 0.52 to 0.07 | − 0.19 | − 0.58 to 0.20 | 43.11 | 42.72 to 43.49 | − 0.04 | − 0.38 to 0.30 |